Adding Whole Pelvic Radiation to Chemotherapy May Prolong Survival in Advanced Cervical Cancer
Data indicate that the addition of WPR to chemotherapy may provide a survival benefit, though prospective studies are needed to confirm these findings.
Society of Gynecologic Oncology (SGO)
Adjuvant Chemotherapy Without Radiation Effective in Stage IB-IIA Cervical Cancer
Data suggest that adjuvant chemotherapy without radiation may be an effective option for patients with stage IB to IIA cervical cancer with risk factors.
Aggressive Endometrial Cancer Subtypes More Common in African American Population
Study results suggest that aggressive molecular subtypes of endometrial cancer are more common among the African American population.
Burnout and Productivity Loss Among Gynecologic Oncologists
Gynecologic oncologists are at a particularly high risk for burnout compared with other specialties, suggesting a need for burnout prevention and wellness programs.
Hospital Readmission Reduction Program May Unfairly Penalize Hospitals
The Hospital Readmission Reduction Program may unfairly penalize hospitals if 30-day readmission rates are the only metric for care quality.
Isolated Tumor Cells and Routine Adjuvant Chemotherapy in Endometrial Cancer
Patients with endometrial cancer who have isolated tumor cells identified by sentinel lymph node mapping should not routinely receive adjuvant chemotherapy.
BRCA1, RAD51C Methylation Linked to Response to PARP Inhibitors
BRCA1 and RAD51C methylation in ovarian carcinomas are associated with sensitivity to PARP inhibitors, such as rucaparib.
Cervical Cancer: SLN Biopsy Associated With Fewer Complications
Sentinel lymph node biopsy was associated with fewer surgical complications, less lymphedema, and better quality of life.
Want to read more?
Please login or register first to view this content.
Next post in SGO 2017
